---
title: "Zhongxing BioTech has repurchased a total of 16.0832 million shares at a cost of 125 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223791229.md"
description: "According to the Zhitong Finance APP, Zhongxing BioTech announced that as of December 31, 2024, the company has repurchased a total of 16.0832 million shares through centralized bidding, accounting for 4.0899% of the company's current total share capital, with a total payment of 125 million yuan (excluding transaction fees, etc.)"
datetime: "2025-01-02T11:20:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223791229.md)
  - [en](https://longbridge.com/en/news/223791229.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223791229.md)
generator: "portal-rs"
---

# Zhongxing BioTech has repurchased a total of 16.0832 million shares at a cost of 125 million yuan

According to the Zhitong Finance APP, Zhongxing BioTech (002772.SZ) announced that as of December 31, 2024, the company has repurchased a total of 16.0832 million shares through centralized bidding, accounting for 4.0899% of the company's current total share capital, with a total payment amount of 125 million yuan (excluding transaction fees, etc.)

### Related Stocks

- [002772.CN](https://longbridge.com/en/quote/002772.CN.md)

## Related News & Research

- [U.S. job openings rise to 7.271 million in July](https://longbridge.com/en/news/297664395.md)
- [Uniao Pet Participacoes: Grupo Petz Cobasi drives growth in Brazil's booming pet market with omnichannel leadership and synergy gains](https://longbridge.com/en/news/297552330.md)
- [UK fintech Allica Bank looks to crack European market](https://longbridge.com/en/news/297498349.md)
- [Motus FY26 earnings per share rise 19% to 1,753 cents; revenue climbs 1% to ZAR 113.55 billion](https://longbridge.com/en/news/297734398.md)
- [BYD deepens PaXini ties, opens auto factories to robots](https://longbridge.com/en/news/297518424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**